ARTV
Price
$4.03
Change
+$0.16 (+4.13%)
Updated
Feb 6 closing price
Capitalization
98.92M
49 days until earnings call
Intraday BUY SELL Signals
IMRN
Price
$0.81
Change
+$0.03 (+3.85%)
Updated
Feb 6 closing price
Capitalization
6.71M
24 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ARTV vs IMRN

Header iconARTV vs IMRN Comparison
Open Charts ARTV vs IMRNBanner chart's image
Artiva Biotherapeutics
Price$4.03
Change+$0.16 (+4.13%)
Volume$145.05K
Capitalization98.92M
Immuron
Price$0.81
Change+$0.03 (+3.85%)
Volume$25.84K
Capitalization6.71M
ARTV vs IMRN Comparison Chart in %
ARTV
Daily Signal:
Gain/Loss:
IMRN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ARTV vs. IMRN commentary
Feb 09, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARTV is a Hold and IMRN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 09, 2026
Stock price -- (ARTV: $4.03 vs. IMRN: $0.81)
Brand notoriety: ARTV and IMRN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARTV: 11% vs. IMRN: 4%
Market capitalization -- ARTV: $98.92M vs. IMRN: $6.71M
ARTV [@Biotechnology] is valued at $98.92M. IMRN’s [@Biotechnology] market capitalization is $6.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.26B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARTV’s FA Score shows that 0 FA rating(s) are green whileIMRN’s FA Score has 1 green FA rating(s).

  • ARTV’s FA Score: 0 green, 5 red.
  • IMRN’s FA Score: 1 green, 4 red.
According to our system of comparison, ARTV is a better buy in the long-term than IMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARTV’s TA Score shows that 3 TA indicator(s) are bullish while IMRN’s TA Score has 4 bullish TA indicator(s).

  • ARTV’s TA Score: 3 bullish, 4 bearish.
  • IMRN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, IMRN is a better buy in the short-term than ARTV.

Price Growth

ARTV (@Biotechnology) experienced а +3.60% price change this week, while IMRN (@Biotechnology) price change was -13.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.30%. For the same industry, the average monthly price growth was -2.98%, and the average quarterly price growth was +31.79%.

Reported Earning Dates

ARTV is expected to report earnings on Mar 30, 2026.

IMRN is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (-2.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARTV($98.9M) has a higher market cap than IMRN($6.71M). IMRN YTD gains are higher at: 5.679 vs. ARTV (-6.061). IMRN has higher annual earnings (EBITDA): -7.35M vs. ARTV (-83.6M). ARTV has more cash in the bank: 123M vs. IMRN (7.74M). IMRN has higher revenues than ARTV: IMRN (6.54M) vs ARTV (0).
ARTVIMRNARTV / IMRN
Capitalization98.9M6.71M1,474%
EBITDA-83.6M-7.35M1,138%
Gain YTD-6.0615.679-107%
P/E RatioN/AN/A-
Revenue06.54M-
Total Cash123M7.74M1,590%
Total Debt11.7MN/A-
FUNDAMENTALS RATINGS
IMRN: Fundamental Ratings
IMRN
OUTLOOK RATING
1..100
98
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARTVIMRN
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
76%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 18 days ago
86%
Bullish Trend 18 days ago
73%
Declines
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
76%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
ARTV
Daily Signal:
Gain/Loss:
IMRN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OLOX1.050.09
+9.07%
Olenox Industries Inc.
BXC79.052.50
+3.27%
BlueLinx Holdings
CNK25.770.40
+1.58%
Cinemark Holdings
KVAC12.00N/A
N/A
Keen Vision Acquisition Corp
FWONK85.25-1.91
-2.19%
Liberty Media Corp

ARTV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARTV has been closely correlated with QNCX. These tickers have moved in lockstep 94% of the time. This A.I.-generated data suggests there is a high statistical probability that if ARTV jumps, then QNCX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARTV
1D Price
Change %
ARTV100%
+4.13%
QNCX - ARTV
94%
Closely correlated
-4.79%
MREO - ARTV
89%
Closely correlated
+13.20%
TPST - ARTV
89%
Closely correlated
+7.62%
CALC - ARTV
89%
Closely correlated
-1.77%
BDRX - ARTV
82%
Closely correlated
-4.62%
More

IMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMRN has been closely correlated with ARTV. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if IMRN jumps, then ARTV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMRN
1D Price
Change %
IMRN100%
+3.31%
ARTV - IMRN
82%
Closely correlated
+4.13%
LABFF - IMRN
81%
Closely correlated
N/A
VTGN - IMRN
79%
Closely correlated
+11.52%
QNCX - IMRN
77%
Closely correlated
-4.79%
TPST - IMRN
74%
Closely correlated
+7.62%
More